Product Images Cisplatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Cisplatin NDC 68001-283 by Bluepoint Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

S:\Departments\BPLabs\Quality & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 100ML CARTON Rev 03_16.JPG - cisplatin inj 100mg carton

S:\Departments\BPLabs\Quality  & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 100ML CARTON Rev 03_16.JPG - cisplatin inj 100mg carton

This is a medication information label. The medicine is an injection of 100 mg/100 ml Cisplatin, a cytotoxic agent used intravenously. It is mostly used for cancer treatment. It is recommended to be stored at a controlled room temperature, but refrigeration is allowed. The package insert should be consulted for instructions and dosage information.*

S:\Departments\BPLabs\Quality & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 100ML LABEL Rev 03_16.JPG - cisplatin inj 100mg label

S:\Departments\BPLabs\Quality  & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 100ML LABEL Rev 03_16.JPG - cisplatin inj 100mg label

This is a description of a sterile solution called "Cisplatin Injection." It contains 1 mg of cisplatin and 9 mg of sodium chloride per mL of water for injection, with HCl and/or sodium hydroxide added to adjust the pH to a range of 3.5 to 5.0. The solution should not be refrigerated or frozen, as it may form a precipitate or crystal. The manufacturer is Intas Pharmaceuticals Limited in Ahmedabad, India. It is a cytotoxic agent and is used for intravenous use. The usual dosage should be determined by a healthcare professional. The container closure does not contain natural rubber latex.*

S:\Departments\BPLabs\Quality & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 50ML CARTON Rev 03_16.JPG - cisplatin inj 50mg carton

S:\Departments\BPLabs\Quality  & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 50ML CARTON Rev 03_16.JPG - cisplatin inj 50mg carton

S:\Departments\BPLabs\Quality & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 50ML LABEL Rev 03_16.JPG - cisplatin inj 50mg label

S:\Departments\BPLabs\Quality  & Regulatory\Regulatory\ARTWORK FILES BLUEPOINT\Intas Pharmaceuticals Limited Artwork\Cisplatin Injection\Approved\CISPLATIN INJECTION 50ML LABEL Rev 03_16.JPG - cisplatin inj 50mg label

Sterile CiSPLatin Injection is a medication containing 1mg cisplatin and 9mg sodium chloride in water for injection. The pH range of the injection is 3.5 to 5.0. It is not recommended to refrigerate or freeze the solution as it may lead to the formation of precipitate or crystal. The injection is not made with natural rubber latex. Usual dosage information can be found in the insert. The medication is manufactured by Intas Pharmaceuticals Limited in India for BluePoint Laboratories. Store at controlled room temperature between 15°C to 30°C.*

Chemical Structure - cisplatin structure

Chemical Structure - cisplatin structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.